Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling.
Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat, and despite of advances in treatment, the overall survival rate has only modestly improved over the past several years. Thus, there is an urgent need for additional therapeutic modalities. We hypothesized that treatment of HNS...
Main Authors: | Ananthi Rajamoorthi, Shubham Shrivastava, Robert Steele, Pratibha Nerurkar, Juan G Gonzalez, Susan Crawford, Mark Varvares, Ratna B Ray |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3798549?pdf=render |
Similar Items
-
Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling
by: Subhayan Sur, et al.
Published: (2021-03-01) -
<it>Momordica charantia </it>(bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
by: Nerurkar Vivek R, et al.
Published: (2010-06-01) -
Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
by: Feher Domonkos, et al.
Published: (2011-06-01) -
Strategies to improve palatability and increase consumption intentions for <it>Momordica charantia </it>(bitter melon): A vegetable commonly used for diabetes management
by: Shovic Anne C, et al.
Published: (2011-07-01) -
Bitter Melon (<i>Momordica Charantia</i>), a Nutraceutical Approach for Cancer Prevention and Therapy
by: Subhayan Sur, et al.
Published: (2020-07-01)